Follow
Scot Garg
Scot Garg
East Lancashire Hospitals NHS Trust
Verified email at elht.nhs.uk
Title
Cited by
Cited by
Year
Guidelines on myocardial revascularization: the task force on myocardial revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio …
Developed with the Special Contribution of the European Association for ...
European heart journal 31 (20), 2501-2555, 2010
36712010
Comparison of zotarolimus-eluting and everolimus-eluting coronary stents
PW Serruys, S Silber, S Garg, RJ van Geuns, G Richardt, PE Buszman, ...
New England journal of medicine 363 (2), 136-146, 2010
7592010
Assessment of the SYNTAX score in the Syntax study
PW Serruys, Y Onuma, S Garg, G Sarno, M van den Brand, AP Kappetein, ...
EuroIntervention 5 (1), 50-56, 2009
7532009
Genome-wide meta-analysis identifies 11 new loci for anthropometric traits and provides insights into genetic architecture
SI Berndt, S Gustafsson, R Mägi, A Ganna, E Wheeler, MF Feitosa, ...
Nature genetics 45 (5), 501-512, 2013
7322013
Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy …
P Vranckx, M Valgimigli, P Jüni, C Hamm, PG Steg, D Heg, GA van Es, ...
The Lancet 392 (10151), 940-949, 2018
6752018
Coronary stents: current status
S Garg, PW Serruys
Journal of the American College of Cardiology 56 (10S), S1-S42, 2010
6742010
Effects of the Direct Lipoprotein-Associated Phospholipase A2 Inhibitor Darapladib on Human Coronary Atherosclerotic Plaque
PW Serruys, HM García-García, P Buszman, P Erne, S Verheye, ...
Circulation 118 (11), 1172-1182, 2008
5912008
Stent thrombosis
DR Holmes, DJ Kereiakes, S Garg, PW Serruys, GJ Dehmer, SG Ellis, ...
Journal of the American College of Cardiology 56 (17), 1357-1365, 2010
5212010
Coronary stents: looking forward
S Garg, PW Serruys
Journal of the American College of Cardiology 56 (10S), S43-S78, 2010
3782010
A new tool for the risk stratification of patients with complex coronary artery disease: the Clinical SYNTAX Score
S Garg, G Sarno, HM Garcia-Garcia, C Girasis, J Wykrzykowska, ...
Circulation: Cardiovascular Interventions 3 (4), 317-326, 2010
3452010
5-year clinical outcomes of the ARTS II (Arterial Revascularization Therapies Study II) of the sirolimus-eluting stent in the treatment of patients with multivessel de novo …
PW Serruys, Y Onuma, S Garg, P Vranckx, B De Bruyne, MC Morice, ...
Journal of the American College of Cardiology 55 (11), 1093-1101, 2010
3072010
Value of the SYNTAX score for risk assessment in the all-comers population of the randomized multicenter LEADERS (Limus Eluted from A Durable versus ERodable Stent coating) trial
JJ Wykrzykowska, S Garg, C Girasis, T De Vries, MA Morel, GA Van Es, ...
Journal of the American College of Cardiology 56 (4), 272-277, 2010
2832010
Prognostic implications of coronary calcification in patients with obstructive coronary artery disease treated by percutaneous coronary intervention: a patient-level pooled …
CV Bourantas, YJ Zhang, S Garg, J Iqbal, M Valgimigli, S Windecker, ...
Heart 100 (15), 1158-1164, 2014
2712014
SYNTAX score and Clinical SYNTAX score as predictors of very long-term clinical outcomes in patients undergoing percutaneous coronary interventions: a substudy of SIRolimus …
C Girasis, S Garg, L Räber, G Sarno, MA Morel, HM Garcia-Garcia, ...
European heart journal 32 (24), 3115-3127, 2011
2172011
Prediction of 1-year clinical outcomes using the SYNTAX score in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary …
S Garg, G Sarno, PW Serruys, AE Rodriguez, L Bolognese, M Anselmi, ...
JACC: Cardiovascular Interventions 4 (1), 66-75, 2011
2152011
Value of the SYNTAX score in patients treated by primary percutaneous coronary intervention for acute ST-elevation myocardial infarction: The MI SYNTAXscore study
M Magro, S Nauta, C Simsek, Y Onuma, S Garg, E van der Heide, ...
American heart journal 161 (4), 771-781, 2011
1682011
Value of age, creatinine, and ejection fraction (ACEF score) in assessing risk in patients undergoing percutaneous coronary interventions in the ‘all-comers' leaders trial
JJ Wykrzykowska, S Garg, Y Onuma, T de Vries, D Goedhart, MA Morel, ...
Circulation: Cardiovascular Interventions 4 (1), 47-56, 2011
1502011
The prognostic utility of the SYNTAX score on 1-year outcomes after revascularization with zotarolimus-and everolimus-eluting stents: a substudy of the RESOLUTE All Comers Trial
S Garg, PW Serruys, S Silber, J Wykrzykowska, RJ van Geuns, G Richardt, ...
JACC: Cardiovascular Interventions 4 (4), 432-441, 2011
1382011
New concepts in the design of drug-eluting coronary stents
S Garg, C Bourantas, PW Serruys
Nature Reviews Cardiology 10 (5), 248-260, 2013
1342013
3-year clinical follow-up of the XIENCE V everolimus-eluting coronary stent system in the treatment of patients with de novo coronary artery lesions: the SPIRIT II trial …
S Garg, P Serruys, Y Onuma, C Dorange, S Veldhof, K Miquel-Hébert, ...
JACC: Cardiovascular Interventions 2 (12), 1190-1198, 2009
1252009
The system can't perform the operation now. Try again later.
Articles 1–20